IMD Genotype Functional analysis of iPSC hepatocytes and comments Reference
1 α1-antitrypsin deficiency (A1ATD) Homozygous Glu342Lys mutation in Z allele Polymerized AAT protein demonstrated in the mutant iPSC-hepatocytes. Rashid et al. [36]    
Glycogen storage disease type 1 a (GSD1a) Deficiency of hepatic glucose-6-phosphatase enzyme Increased accumulation of glycogen in the cytoplasm of differentiated hepatocytes.
Familial hypercholesterolemia (FH) Defective LDL receptor (Autosomal-dominant mutation) Demonstrated defect in LDL uptake by mutant iPSC-hepatocytes.
Crigler-Najjar syndrome Homozygous for 13-bp deletion in exon 2 of UGT1A1 gene Disease phenotype not characterized.
Hereditary tyrosinemia type 1 Val166Gly codon substitution in one of fumarylacetoacetate hydrolase (FAH) alleles Disease phenotype not characterized.
2 Hereditary tyrosinemia type 1 FAH protein codon substitution Gln64His Disease phenotype not characterized. Ghodsizadeh et al. [51]    
Glycogen storage disease type 1 a (GSD1a) SLC37A gene mutation 1124- 2A>G Disease phenotype not characterized.
Progressive familial hereditary cholestasis Multifactorial Disease phenotype not characterized.
Crigler-Najjar syndrome UGT1A1 protein missense mutation Leu413Pro Disease phenotype not characterized.
3 Wilson's disease (WD) Arg778Leu substitution in ATP7B Mislocalization of mutant ATP7B protein and lack of copper transport function in iPSC-hepatocytes. Zhang et al. [52]
Table 2: Generation and characterization of iPSC lines derived from patients with inherited metabolic disorders (IMD).